5% MINOXIDIL HAIR REGROWTH SERUM With Biotin

Manufacturer
Guangzhou Borderless Technology Co., Ltd.
Effective date
2026-03-09
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:49:22

Label at a glance#

Product5% MINOXIDIL HAIR REGROWTH SERUM With Biotin
Active ingredientMINOXIDIL, BIOTIN
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Minoxidil 5%
Biotin 0.2%

OTC - PURPOSE SECTION

Hair Regrowth

INDICATIONS & USAGE SECTION

Use to regrow hair of the scalp and beard growth for men

WARNINGS SECTION


For external use only.
Keep out of reach of children,

OTC - DO NOT USE SECTION


You have no family history of hair loss.
Your hair loss is sudden and/or patchy.
Your hair loss is associated with childbirth.
You do not know the reason for your hair loss
You are under 18 years of age. Do not use on babies and children.
Your scalp is red, inflamed, infected, irritated, or painful.
You use other medicines on the scalp.

OTC - WHEN USING SECTION

Avoid contact with eyes. In case of accidental contact, rinse eyes with a large amount of cool tap water.

OTC - STOP USE SECTION


Chest pain, rapid heartbeat, faintness, or dizziness occurs.
Sudden, unexplained weight gain occurs
Scalp irritation or redness occurs.
Keep out of reach of children.
lf swallowed, get medical help or contact a Poison Control Center
(1-800-222-1222) right away.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

DOSAGE & ADMINISTRATION SECTION


Apply 3-6 drops Minoxidil Serum directly onto scalp on the hair loss area
Use fingertips to massage solution into skin/hair for 1 minutes then wash hands thoroughly.
Used once daily on clean dry hair for best results

INACTIVE INGREDIENT SECTION

Butylene Glycol
Glycerin
Alcohol
Panthenol
Water

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label1label1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2707693biotin 0.2 % / minoxidil 5 % Topical SolutionPSN2
2707693biotin 2 MG/ML / minoxidil 50 MG/ML Topical SolutionSCD2
2707693biotin 0.2 % / minoxidil 5 % Topical SolutionSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MINOXIDIL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130769310806879GTIN-13: 0769310806879
EAN-13: 0769310806879
GTIN-12: 769310806879
UPC-A: 769310806879
GTIN storage (14 digits): 00769310806879
label1.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85304-027-015% MINOXIDIL HAIR REGROWTH SERUM With Biotin60 mL in 1 BOTTLELIQUID602
85304-027-015% MINOXIDIL HAIR REGROWTH SERUM With Biotin2 in 1 PACKAGELIQUID22

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85304-02785304-027-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
5% MINOXIDIL HAIR REGROWTH SERUM With BiotinMINOXIDILGuangzhou Borderless Technology Co., Ltd.4c92193d-8910-be62-e063-6294a90ae28e2026-03-09WarningsExact identifier
ndc (package): 85304-027-01
ndc (product): 85304-027
ndc11 (package): 85304002701
spl id: 4c936397-1056-078a-e063-6294a90a7c12
spl set id: 4c92193d-8910-be62-e063-6294a90ae28e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.